Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazha Hamdani

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 6, 2025
Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implicationsFabienne Kreimer, Pia Thiesing, Ibrahim Akin, et al.
Journal of Clinical Medicine|May 25, 2024
Ejection Fraction-Related Differences of Baseline Characteristics and Outcomes in Troponin-Positive Patients without Obstructive Coronary Artery DiseaseMustafa Kacmaz, Clara Schlettert, Fabienne Kreimer, et al.
Cells|September 13, 2025
miR-451 Is a Driver of Lipotoxic Injury in Patients with Diabetic CardiomyopathySarah Costantino, Shafeeq A Mohammed, Federico Ranocchi, et al.
ESC Heart Failure|October 19, 2020
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trialMariëlle Scheffer, Annet Driessen-Waaijer, Nazha Hamdani, et al.
Journal of Cellular and Molecular Medicine|December 9, 2020
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylationIlona Cuijpers, Anna-Pia Papageorgiou, Paolo Carai, et al.
Circulation. Heart Failure|September 6, 2024
Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection FractionJoão Almeida-Coelho, André M Leite-Moreira, Vasco Sequeira, et al.
European Journal of Heart Failure|November 29, 2018
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyondCarsten Tschöpe, Behrouz Kherad, Oliver Klein, et al.
Circulation. Heart Failure|April 21, 2026
Correction to: Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection FractionJoão Almeida-Coelho, André M Leite-Moreira, Vasco Sequeira, et al.
European Journal of Clinical Investigation|May 9, 2025
Impact of smoking in MINOCA patientsHersh Osman, Clara Schlettert, Daniel Materzok, et al.
Frontiers in Cardiovascular Medicine|January 3, 2025
Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanMohammad Abumayyaleh, Carina Krack, Jonathan Demmer, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 6, 2025
Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implicationsFabienne Kreimer, Pia Thiesing, Ibrahim Akin, et al.
Journal of Clinical Medicine|May 25, 2024
Ejection Fraction-Related Differences of Baseline Characteristics and Outcomes in Troponin-Positive Patients without Obstructive Coronary Artery DiseaseMustafa Kacmaz, Clara Schlettert, Fabienne Kreimer, et al.
Cells|September 13, 2025
miR-451 Is a Driver of Lipotoxic Injury in Patients with Diabetic CardiomyopathySarah Costantino, Shafeeq A Mohammed, Federico Ranocchi, et al.
ESC Heart Failure|October 19, 2020
Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trialMariëlle Scheffer, Annet Driessen-Waaijer, Nazha Hamdani, et al.
Journal of Cellular and Molecular Medicine|December 9, 2020
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylationIlona Cuijpers, Anna-Pia Papageorgiou, Paolo Carai, et al.
Circulation. Heart Failure|September 6, 2024
Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection FractionJoão Almeida-Coelho, André M Leite-Moreira, Vasco Sequeira, et al.
European Journal of Heart Failure|November 29, 2018
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyondCarsten Tschöpe, Behrouz Kherad, Oliver Klein, et al.
Circulation. Heart Failure|April 21, 2026
Correction to: Myosin-Inhibitor Mavacamten Acutely Enhances Cardiomyocyte Diastolic Compliance in Heart Failure With Preserved Ejection FractionJoão Almeida-Coelho, André M Leite-Moreira, Vasco Sequeira, et al.
European Journal of Clinical Investigation|May 9, 2025
Impact of smoking in MINOCA patientsHersh Osman, Clara Schlettert, Daniel Materzok, et al.
Frontiers in Cardiovascular Medicine|January 3, 2025
Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanMohammad Abumayyaleh, Carina Krack, Jonathan Demmer, et al.
Pageof 18